AIDS treatment in Brazil: Impacts and challenges

Health Affairs

Volumn 28, Issue 4, 2009, Pages 1103-1113

  Nunn, Amy Stewart ^a   Da Fonseca, Elize Massard ^b   Bastos, Francisco I ^c   Gruskin, Sofia ^d,e  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Program on International Health and Human Rights   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAZIL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE TRANSMISSION; DRUG COST; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV EDUCATION; HUMAN; MORBIDITY; MORTALITY; PREVALENCE; PUBLIC HEALTH SERVICE; REVIEW; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-RETROVIRAL AGENTS; BRAZIL; DRUG COSTS; HEALTH EDUCATION; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; PROGRAM EVALUATION;

EID: 67651236325     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.4.1103     Document Type: Review

References (20)

1. J.R. Marins et al., "Dramatic Improvement in Survival among Adult Brazilian AIDS Patients," AIDS 17, no. 11 (2003): 1675-1682;
2. and A. de Brito et al., "Trends in Maternal-Infant Transmission of AIDS after Antiretroviral Therapy in Brazil" (in Portuguese), Revista de Saúde Pública 40 Supp. (2006): 18-22.
3. I. Dourado et al., "AIDS Epidemic Trends after the Introduction of Antiretroviral Therapy in Brazil" (in Portuguese), Revista de Saúde Pública 40 Supp. (2006): 91-97.
4. A. Nunn, The Politics and History of AIDS Treatment in Brazil (New York: Springer International, 2008).
5. Authors' interviews with Brazilian President Fernando Cardoso, Health Minister Jose Serra, and National AIDS Program Director Paulo Teixeira, 2005 and 2006.
6. Authors' interviews with Legal Aid attorneys Miriam Ventura, Ingrid Carvalho, and Rosana Del Bianco, 2005;
7. and J. Galvão, "Brazil and Access to HIV/AIDS Drugs: A Question of Human Rights and Public Health," American Journal of Public Health 95, no. 7 (2005): 1110-1116.
8. United Nations General Assembly Special Session, "HIV/AIDS: Brazilian Response 2005/2007 Country Progress Report" (New York: UNGASS, 2008).
9. A. Nunn et al., "Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment," PLoS Medicine 4, no. 11 (2007): e305.
10. A. Nunn, E.D. Fonseca, and S. Gruskin, "Changing Global Essential Medicines Norms to Improve AIDS Treatment: Lessons from Brazil," Global Public Health 4, no. 2 (2008): 130-149.
11. Nunn et al., "Evolution of Antiretroviral Drug Costs."
12. A. Barry, "The Deadlock of Democracy in Brazil," in Interests, Identities, and Institutions in Comparative Politics, ed. M. Lichbach (Ann Arbor: University of Michigan Press, 2002).
13. UNGASS, "HIV/AIDS: Brazilian Response 2005/2007."
14. Departamento de Informática do SUS (DATASUS), "Gastos Para Medicamentos Excepcionais Pacientes Crônicos" (Brasìlia: Ministério da Saúde, 2009);
15. and Coordenação de Acompanhamento e Avaliação (CAA/Ministério da Saúde), "Execução Orçamentária e Financeira 2001-2005" (Brasília: CAA, 2005).
16. D. Kerrigan et al., "The Search for Social Validation and the Sexual Behavior of People Living with HIV in Rio de Janeiro, Brazil: Understanding the Role of Treatment Optimism in Context," Social Science and Medicine 62, no. 10 (2006): 2386-2396.
17. Dourado et al., "AIDS Epidemic Trends."
18. J.S. Montaner et al., "The Case for Expanding Access to Highly Active Antiretroviral Therapy to Curb the Growth of the HIV Epidemic," Lancet 368, no. 9534 (2006): 531-536.
19. The Tom Lantos and Henry J. Hyde United States Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, PL 110-293: To Authorize Appropriations for Fiscal Years 2009 through 2013 to Provide Assistance to Foreign Countries to Combat HIV/AIDS, Tuberculosis, and Malaria, and for Other Purposes (2008).
20. Doctors Without Borders, "MSF Welcomes New Fixed-Dose Combination Against Malaria Developed through a Partnership between DNDI and Farmanguinhos, ASMQ Combines Artesunate (AS) and Mefloquine (MQ) in One Fixed Dose," 17 April 2008, http://www.msf.org/au/resources/position-papers.html (accessed 11 April 2009).